Immunome IMNM
NASDAQ IMNM
$20.90 +0.01 (+0.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immunome (IMNM) Cash & Current Investments (2019 - 2026)

Updated

Immunome's Cash & Current Investments was $520.01 million in Q2 2026, up 94.0% from $268.08 million a year earlier but down 10.8% from the prior quarter.

Analysis

Immunome (IMNM) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Immunome came in at $653.48 million, up 200.7% from FY2024.

  • Cash & Current Investments has now increased for three consecutive years, with a five-year compound annual growth rate of 75.0% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $217.3 million in FY2024 (+57.3%), $138.14 million in FY2023 (+579.7%), $20.32 million in FY2022 (-58.7%) and $49.23 million in FY2021 (+23.8%).
  • Quarterly Cash & Current Investments has moved between $20.32 million (Q4 2022) and $653.48 million (Q4 2025) over five years.
  • Compared with a year earlier, Cash & Current Investments has increased for four straight quarters, with growth averaging 76.6% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q3 2021 (growth of 734.0%); the worst was Q4 2022 (a decline of 58.7%).
  • Per Business Quant data, IMNM's Cash & Current Investments in the three quarters before Q2 2026 was $582.7 million (Q1 2026), $653.48 million (Q4 2025) and $272.64 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Immunome 2.37 Bn 341.22 Mn - 520.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 520.01 Mn
Mar 31, 2026 582.70 Mn
Dec 31, 2025 653.48 Mn
Sep 30, 2025 272.64 Mn
Jun 30, 2025 268.08 Mn
Mar 31, 2025 317.32 Mn
Dec 31, 2024 217.30 Mn
Sep 30, 2024 240.17 Mn
Jun 30, 2024 278.35 Mn
Mar 31, 2024 309.72 Mn
Dec 31, 2023 138.14 Mn
Sep 30, 2023 90.64 Mn
Jun 30, 2023 38.42 Mn
Mar 31, 2023 44.42 Mn
Dec 31, 2022 20.32 Mn
Sep 30, 2022 27.08 Mn
Jun 30, 2022 34.65 Mn
Mar 31, 2022 42.88 Mn
Dec 31, 2021 49.23 Mn
Sep 30, 2021 56.24 Mn
API Access

Immunome Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IMNM&period=max&api_key=YOUR_API_KEY